Target Price | $2,860.14 |
Price | $2,563.29 |
Potential | 11.58% |
Number of Estimates | 22 |
22 Analysts have issued a price target MercadoLibre 2026 . The average MercadoLibre target price is $2,860.14. This is 11.58% higher than the current stock price. The highest price target is $3,200.00 24.84% , the lowest is $2,450.00 4.42% . | |
A rating was issued by 26 analysts: 22 Analysts recommend MercadoLibre to buy, 3 to hold and 1 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the MercadoLibre stock has an average upside potential 2026 of 11.58% . Most analysts recommend the MercadoLibre stock at Purchase. |
19 Analysts have issued a sales forecast MercadoLibre 2025 . The average MercadoLibre sales estimate is $27.2b . This is 21.45% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $28.7b 28.14% , the lowest is $25.7b 15.04% .
This results in the following potential growth metrics:
2024 | $20.8b | 43.56% |
---|---|---|
2025 | $27.2b | 30.81% |
2026 | $33.8b | 24.35% |
2027 | $40.9b | 20.87% |
2028 | $49.7b | 21.69% |
19 Analysts have issued an MercadoLibre EBITDA forecast 2025. The average MercadoLibre EBITDA estimate is $4.4b . This is 25.99% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $5.1b 46.79% , the lowest is $4.0b 15.44% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | $3.2b | 56.30% |
---|---|---|
2025 | $4.4b | 35.81% |
2026 | $5.8b | 32.03% |
2027 | $7.5b | 29.17% |
2028 | $9.7b | 29.11% |
2024 | 15.63% | 8.88% |
---|---|---|
2025 | 16.23% | 3.82% |
2026 | 17.23% | 6.16% |
2027 | 18.41% | 6.85% |
2028 | 19.54% | 6.14% |
11 MercadoLibre Analysts have issued a net profit forecast 2025. The average MercadoLibre net profit estimate is $2.5b . This is 21.85% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $3.0b 44.28% , the lowest is $2.3b 10.83% .
This results in the following potential growth metrics and future Net Margins:
2024 | $1.9b | 93.62% |
---|---|---|
2025 | $2.5b | 31.41% |
2026 | $3.5b | 37.52% |
2027 | $4.6b | 33.59% |
2024 | 9.20% | 34.87% |
---|---|---|
2025 | 9.24% | 0.46% |
2026 | 10.22% | 10.61% |
2027 | 11.29% | 10.47% |
11 Analysts have issued a MercadoLibre forecast for earnings per share. The average MercadoLibre EPS is $49.76 . This is 22.44% higher than earnings per share in the financial year 2024. The highest EPS forecast is $58.92 44.98% , the lowest is $45.26 11.37% .
This results in the following potential growth metrics and future valuations:
2024 | $37.69 | 94.78% |
---|---|---|
2025 | $49.76 | 32.02% |
2026 | $68.43 | 37.52% |
2027 | $91.41 | 33.58% |
Current | 63.07 | 17.02% |
---|---|---|
2025 | 51.51 | 18.33% |
2026 | 37.46 | 27.28% |
2027 | 28.04 | 25.15% |
Based on analysts' sales estimates for 2025, the MercadoLibre stock is valued at an EV/Sales of 4.72 and an P/S ratio of 4.78 .
This results in the following potential growth metrics and future valuations:
Current | 5.73 | 10.83% |
---|---|---|
2025 | 4.72 | 17.60% |
2026 | 3.80 | 19.58% |
2027 | 3.14 | 17.27% |
2028 | 2.58 | 17.82% |
Current | 5.81 | 9.93% |
---|---|---|
2025 | 4.78 | 17.66% |
2026 | 3.84 | 19.58% |
2027 | 3.18 | 17.27% |
2028 | 2.61 | 17.82% |
Analyst | Rating | Action | Date |
---|---|---|---|
JP Morgan |
Neutral
➜
Neutral
|
Unchanged | May 22 2025 |
Goldman Sachs |
Buy
➜
Buy
|
Unchanged | May 14 2025 |
Barclays |
Overweight
➜
Overweight
|
Unchanged | May 08 2025 |
Cantor Fitzgerald |
Overweight
➜
Overweight
|
Unchanged | Apr 16 2025 |
Benchmark |
➜
Buy
|
Initiated | Apr 15 2025 |
Morgan Stanley |
Overweight
➜
Overweight
|
Unchanged | Apr 10 2025 |
Goldman Sachs |
Buy
➜
Buy
|
Unchanged | Mar 03 2025 |
Analyst Rating | Date |
---|---|
Unchanged
JP Morgan:
Neutral
➜
Neutral
|
May 22 2025 |
Unchanged
Goldman Sachs:
Buy
➜
Buy
|
May 14 2025 |
Unchanged
Barclays:
Overweight
➜
Overweight
|
May 08 2025 |
Unchanged
Cantor Fitzgerald:
Overweight
➜
Overweight
|
Apr 16 2025 |
Initiated
Benchmark:
➜
Buy
|
Apr 15 2025 |
Unchanged
Morgan Stanley:
Overweight
➜
Overweight
|
Apr 10 2025 |
Unchanged
Goldman Sachs:
Buy
➜
Buy
|
Mar 03 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.